Streetbeat News

Products Services

HOTH

Hoth Therapeutics shares rise following the award of a US patent for its HT-ALZ Alzheimer's treatment. The company plans to prepare for clinical trials to validate its efficacy in humans.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:40 am

HOTH

Hoth Therapeutics has been awarded a US patent for its HT-ALZ Alzheimer's treatment. The company is preparing for clinical trials to validate the treatment's efficacy in humans.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:40 am

GMAB

Genmab A/S reported $3 billion in DARZALEX sales for Q3 2024, with royalties from these sales continuing to rise. The sales were reported by Johnson & Johnson, with $1.684 billion in the U.S. and $1.332 billion internationally. Genmab receives royalties from these sales under a license agreement with Janssen.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:27 am

GLD

SPY

USO

U.S. markets closed higher with record highs in the S&P 500 and Dow, led by semiconductors like Arm Holdings and Nvidia. Energy stocks declined due to a drop in crude oil prices. Asian markets were mixed, with significant declines in China. European markets showed mixed results, and crude oil prices fell over 5% due to demand concerns.

Portfolio Pulse from Akanksha Bakshi

October 15, 2024 | 10:16 am

ESCA

Escalade, Inc. (NASDAQ:ESCA) has announced that its subsidiary, US Weight, will be the official U.S. distributor for adidas Fitness accessories. This partnership enhances US Weight's portfolio, which includes brands like Lifeline Fitness and The Step.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:13 am

IBO

Impact BioMedical has announced a significant milestone with the issuance of a Canadian patent for its Linebacker technology, which targets inflammatory diseases. This development could enhance the company's intellectual property portfolio and potentially lead to new market opportunities.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:09 am

IMRN

Immuron reported unaudited sales of its OTC immune supplement, Travelan, totaling AUD$1.5 million for the September 2024 quarter, marking a 13% increase from the previous quarter. Sales in North America saw a significant rise of 48%.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:09 am

AKAM

KD

Akamai Technologies has partnered with Kyndryl to offer micro-segmentation implementation services using Akamai's Guardicore Segmentation. This collaboration aims to enhance security measures for clients by providing advanced segmentation solutions.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:06 am

SHAK

Shake Shack has partnered with Skip, a Canadian delivery network, to offer exclusive delivery and pickup services in Toronto. This partnership allows Torontonians to enjoy Shake Shack's menu from home, expanding Shake Shack's reach in the city.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 10:04 am

MVPA

OCTA

TTE

TotalEnergies SE (NYSE:TTE) shares are down premarket due to expected lower hydrocarbon production levels in Q3, despite higher gas prices and a $1 billion projection for Integrated LNG results. The company plans significant investments in low-carbon energies and has acquired stakes in offshore wind projects.

Portfolio Pulse from Lekha Gupta

October 15, 2024 | 10:00 am